10-YEAR FOLLOW-UP OF PATIENTS WITH POOR PROGNOSIS GERM CELL TUMOR TREATED WITH FIRST-LINE LATE-INTENSIFICATION HIGH-DOSE CHEMOTHERAPY

被引:0
|
作者
Papiani, Giorgio [1 ]
De Giorgi, Ugo [1 ]
Marangolo, Maurizio [1 ]
Rosti, Giovanni [1 ]
机构
[1] Santa Maria delle Croci Hosp, Dept Hematol Oncol, Ravenna, Italy
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:91 / 91
页数:1
相关论文
共 50 条
  • [21] Long-term follow-up after high-dose chemotherapy for paediatric patients with extragonadal germ cell tumour
    De Giorgi, U
    Rosti, G
    Slavin, S
    Yaniv, I
    Harousseau, JL
    Tobler, A
    Ladenstein, R
    Demirer, T
    Dini, G
    BONE MARROW TRANSPLANTATION, 2004, 33 : S40 - S40
  • [22] Phase III Randomized trial of conventional-dose chemotherapy with or without high-dose chemotherapy and autologous hematopoietic stem-cell rescue as first-line treatment for patients with poor-prognosis metastatic germ cell tumors
    Motzer, Robert J.
    Nichols, Craig J.
    Margolin, Kim A.
    Bacik, Jennifer
    Richardson, Paul G.
    Vogelzang, Nicholas J.
    Bajorin, Dean F.
    Lara, Primo N., Jr.
    Einhorn, Lawrence
    Mazumdar, Madhu
    Bosl, George J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (03) : 247 - 256
  • [23] First-line high-dose chemotherapy combined with peripheral blood stem cell transplantation for patients with advanced extragonadal germ cell tumors
    Kumano, Masafumi
    Miyake, Hideaki
    Hara, Isao
    Furukawa, Junya
    Takenaka, Atsushi
    Fujisawa, Masato
    INTERNATIONAL JOURNAL OF UROLOGY, 2007, 14 (04) : 336 - 338
  • [24] Late cardiac effects of chemotherapy in breast cancer survivors treated with adjuvant doxorubicin: 10-year follow-up
    Murtagh, G.
    Lyons, T.
    O'Connell, E.
    Ballot, J.
    Geraghty, L.
    Fennelly, D.
    Gullo, G.
    Ledwidge, M.
    Crown, J.
    Gallagher, J.
    Watson, C.
    McDonald, K. M.
    Walshe, J. M.
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 156 (03) : 501 - 506
  • [25] Late cardiac effects of chemotherapy in breast cancer survivors treated with adjuvant doxorubicin: 10-year follow-up
    G. Murtagh
    T. Lyons
    E. O’Connell
    J. Ballot
    L. Geraghty
    D. Fennelly
    G. Gullo
    M. Ledwidge
    J. Crown
    J. Gallagher
    C. Watson
    K. M. McDonald
    J. M. Walshe
    Breast Cancer Research and Treatment, 2016, 156 : 501 - 506
  • [26] Late cardiac effects of chemotherapy in breast cancer survivors treated with adjuvant Doxorubicin: 10-Year follow-up
    Murtagh, G.
    O'Connell, E.
    Lyons, T.
    Ballot, J.
    Jones, M.
    Geraghty, L.
    Gullo, G.
    Crown, J.
    McDonald, K.
    Walsh, J. M.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S311 - S312
  • [27] High-dose chemotherapy with peripheral blood stem cell transplantation in first-line therapy for advanced germ cell cancer
    Fujii, Y
    Saito, K
    Kawakami, S
    Masada, H
    Hyochi, N
    Yano, M
    Kageyama, Y
    Kihara, K
    JOURNAL OF UROLOGY, 2003, 169 (04): : 239 - 239
  • [28] Is high-dose chemotherapy based on carboplatin, a late dose-intensification of a cisplatin-based salvage chemotherapy in germ cell tumour patients?
    De Giorgi, U
    ANNALS OF ONCOLOGY, 2006, 17 (03) : 530 - U5
  • [29] Is it time to discontinue using high-dose chemotherapy for salvage of patients with advanced germ-cell tumors failing first-line platinum chemotherapy?
    Oyan, B
    Koc, Y
    ANNALS OF ONCOLOGY, 2006, 17 (02) : 349 - 350
  • [30] Successful treatment of disseminated extragonadal germ cell cancer with intensive conventional chemotherapy after first-line high-dose chemotherapy
    Yuasa T.
    Yoshida T.
    Wakabayashi Y.
    Kataoka A.
    Narita M.
    Yoshiki T.
    Okada Y.
    International Journal of Clinical Oncology, 2006, 11 (1) : 60 - 63